Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Revolution Medicines ( (RVMD) ) is now available.
On April 17, 2026, Revolution Medicines issued $500 million of 0.50% Convertible Senior Notes due 2033 as senior unsecured obligations under an indenture with U.S. Bank Trust Company, N.A. as trustee, establishing detailed terms for interest payments, conversion into common stock, redemption conditions, fundamental change repurchase rights, and events of default. The financing, arranged under an April 14, 2026 underwriting agreement with a syndicate led by J.P. Morgan, TD Securities and Guggenheim Securities, provides the company with substantial long-term, low-cost capital while potentially diluting future equity holders upon conversion and adding structured protections and options for both noteholders and the issuer.
The most recent analyst rating on (RVMD) stock is a Buy with a $169.00 price target. To see the full list of analyst forecasts on Revolution Medicines stock, see the RVMD Stock Forecast page.
Spark’s Take on RVMD Stock
According to Spark, TipRanks’ AI Analyst, RVMD is a Neutral.
Score is held back primarily by weak financial performance (rapidly widening losses, heavy cash burn, and minimal/zero recent revenue). Offsetting this are strong technical momentum and meaningful positive clinical/regulatory and financing developments that improve execution capacity, though valuation remains difficult to anchor due to negative earnings.
To see Spark’s full report on RVMD stock, click here.
More about Revolution Medicines
Revolution Medicines, Inc. is a biopharmaceutical company focused on discovering and developing targeted therapies, with its common stock listed on a U.S. exchange. The company participates in the capital markets through issuances of debt and equity securities to fund its operations and strategic initiatives.
Average Trading Volume: 2,825,707
Technical Sentiment Signal: Buy
Current Market Cap: $30.23B
For detailed information about RVMD stock, go to TipRanks’ Stock Analysis page.